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Abstract
Almost all circulating gut peptides contribute to the control of food intake by signalling satiety. One 
important exception is ghrelin, the only orexigenic peptide hormone thus far described. Ghrelin se-
cretion increases before meals and behavioural and electrophysiological evidence shows that ghre-
lin acts in the hypothalamus via homeostatic pathways to signal hunger and increase food intake 
and adiposity. These findings strongly suggest that ghrelin is a dynamically regulated peripheral 
hunger signal. However, ghrelin also interacts with the brain reward pathways to increase food in-
take, alter food preference and enhance food reward. Here we discuss ghrelin’s role as an endocrine 
gut-brain reward signal in relation to homeostatic and hedonic feeding control.
Copyright © 2013 S. Karger AG, Basel
We are bombarded fairly steadily by reports of a high and rising incidence of obesity. 
Being obese is not in itself a problem but the consequences of obesity, like type 2 dia-
betes, cardiovascular diseases and some cancers, are of concern. Food intake is con-
trolled by the brain but what, how much and how often we eat is not only driven by 
homeostatic requirements for calories and nutrients. The existence of what is now la-
belled an obesity epidemic is evidence that many people must have a strong drive to 
eat even when homeostatic signals indicate a positive energy balance in the form of 
large fat stores. However, we do not eat only for energy and nutrients, we also eat for 
pleasure. The target for hedonic-driven eating is a broad category of palatable foods 
with certain characteristics in common. Unfortunately, the foods we enjoy the most 
tend not to be nutritionally balanced, but are high in sugar, fat, salt and calories. What 
is more, hedonic desire for palatable foods can easily inundate the homeostatic mech-
anisms that normally delay the start or signal the termination of feeding. Thus, reward-
driven feeding may drive and support overeating, weight gain, obesity and illness.
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How might this happen? There are several possibilities – firstly, changes in the re-
ward system may be a secondary effect of the onset or maintenance of obesity. The 
central signal most strongly associated with the reinforcing effects of palatable food is 
dopamine released from the mesolimbic structures. In humans, striatal dopamine re-
ceptor number is reduced in obesity [1] and this may be linked to a blunting of the 
normal reward response to food. When neural activity in the striatum is monitored 
in response to palatable food ingestion, individuals show reduced reward responses 
to an identical stimulus after having gained weight [2]. Secondly, and perhaps in con-
trast to this neuroadaptive reprogramming theory, a pre-existing genetic or epigen-
etic susceptibility or sensitivity to reward may exist. For example, striatal D2 receptor 
expression shows interindividual differences related to body weight. But rather than 
an obesity-driven mechanism, inherent differences in expression of the A1 allele of 
the TaqIA polymorphism may underlie this [3]. Selectively bred lines of obesity-prone 
rats (whose phenotypes presumably reflect subtle genetic differences from obesity-
resistant rats) show several impairments in proteins involved in dopamine neuro-
transmission. These are evident before exposure to a palatable diet or excess weight 
gain [4]. Thirdly, the consumption of palatable food may be considered to be a form 
of addiction. In experiments loosely parallel to those of Olds [5] where rats crossed 
electrified grids to self-stimulate their brain reward centres, rats made obese by chron-
ic access to palatable food will continue to eat such food even when conditioned to 
associate its consumption with a painful electric shock [6]. In other words, reward-
related stimuli may compel the consumption of palatable food even in the face of 
marked negative outcomes, real or potential – a classical attribute of addiction [7]. 
None of these three possibilities are mutually-exclusive and other aspects of the re-
ward system may also be important. It is not yet clear whether reward-related obesity 
may be a consequence of hyper- or hypoactivity of the reward system. However, there 
may be strong parallels with other addictive disorders. Hyperactivity of the reward 
system likely drives initial overconsumption of rewarding food but then the behaviour 
becomes reinforced and habitual rather than enjoyable. A hedonic deficit may devel-
op which is compensated for by increased motivation or a craving for the rewarding 
food. This may result in sustained ‘wanting’ in the absence of ‘liking’. In other words, 
eating without pleasure.
In any case, the power of the reward system over feeding behaviour should not be 
underestimated. Compared with homeostatic mechanisms of feeding, much less is 
currently known about how hedonic systems in the brain influence food intake. It is 
clear, however, that hormonal peptide signals converge on certain brain regions and 
are pivotal in both homeostatic and hedonic feeding. Ghrelin is a naturally occurring 
peptide that is found in several regions of the body, including the brain, but is pre-
dominantly synthesised in the mucosal cells of the stomach. Ghrelin is secreted into 
the blood, levels rise during periods of energy depletion, including between normally-
spaced meals, and fall upon feeding. Ghrelin acts centrally to signal hunger and, via 
well-characterised hypothalamic pathways, increases food intake in humans and ro-
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dents [8]. In addition, accumulating evidence points to a role for ghrelin in the mod-
ulation of motivation and reward, not only in feeding but also in responses to artificial 
rewards such as alcohol. Here, we review the target reward pathways for ghrelin, the 
receptors and neurobiological substrates of importance for ghrelin’s effects on food 
intake, food reward and food motivated behaviour.
Ghrelin’s Influence on Central Reward Pathways
The central reward pathways comprise multiple interconnected brain regions many 
of which are sensitive to hormonal peptides commonly associated with the control of 
homeostatic feeding [9]. The best-characterised pathway (now approaching ‘classical’ 
status) is the dopaminergic innervation of the nucleus accumbens (NAcc) by neu-
rones in the ventral tegmental area (VTA). Other regions, especially the target sites of 
the NAcc such as the prefrontal cortex and ventral pallidum, and inputs into the NAcc 
such as the amygdala, are also important for reward processing. Other regions impli-
cated in ghrelin signalling such as the lateral and ventromedial hypothalamus and the 
arcuate nucleus also form neurocircuits with the reward pathways that are likely to be 
important in integrating feeding control [10]. The ghrelin (GHS-R1A) receptor is lo-
calised in many brain regions associated with pleasure, reward and motivation. An 
early report noted GHS-R1A receptor mRNA expression in the substantia nigra and 
VTA and speculated whether receptor localisation in the reward pathway may indi-
cate a role for the then-unidentified endogenous ligand in hedonic motivation [11]. 
Further evidence comes from studies using biotin-labelled ghrelin which binds to 
VTA neurones with a similar pattern of distribution seen to GHS-R1A receptor im-
munoreactivity [12]. GHS-R1A mRNA is translated to express functional ghrelin re-
ceptors in VTA neurones and ghrelin administration to this region causes dopamine 
release [12, 13], although this may be dependent on feeding state [14]. Ghrelin excites 
VTA neurones in brain slices in vitro [12] and increases dopamine activity (as mea-
sured by the DOPAC:dopamine ratio or by microdialysis to directly measure dopa-
mine release in the NAcc) in wild-type and ghrelin knockout mice but not in GHS-
R1A receptor knockout mice [12, 13, 15].
Ghrelin and Natural Rewards: Food and Sex
Readers of this book hardly need to be reminded of ghrelin’s central role in food in-
take. However, the discovery of the peptide solved an apparent mystery. Initially, the 
presence of GHS-R1A receptors in brain regions associated with food intake was not 
easily explained, particularly as most interested parties considered this receptor to be 
the target for a class of synthetic growth hormone secretagogues and, as such, are pre-
sumably mainly involved in the control of growth hormone secretion by an endoge-
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nous ligand. Aware of the localisation of somatostatin- and GHRH-containing neu-
rones for example, most expected a hypothalamic source for an endogenous GHS-
R1A ligand, perhaps released from neuroendocrine cells into the blood to target 
somatotrophs. The finding that ghrelin was synthesised in and secreted from the 
stomach was unanticipated, even by its discoverers [16, 17]. The peptide’s localisation 
in the stomach and the localisation of GHS-R1A receptors in the arcuate and ventro-
medial nuclei drove a clear research direction addressing potential roles in food in-
take. Very soon ghrelin was shown to have effects on food intake, body weight and 
body composition in rodents [18–20] and evidence for changes in obese or anorexic 
humans followed [21, 22]. Several years’ productive effort was focused on ghrelin’s 
role in the homeostatic control of feeding, mainly via its direct excitatory action at 
orexigenic NPY/AgRP/GABA neurones in the hypothalamic arcuate and ventrome-
dial nuclei. Latterly though, attention has turned to the reward pathway as an impor-
tant target [9, 23].
Ghrelin induces an acute orexigenic response when administered peripherally [24] 
or directly into the brain ventricles [25]. In 2005, Naleid et al. [27] demonstrated an 
orexigenic response following direct administration of low doses of ghrelin into the 
VTA and also the NAcc [26], a finding that we have since been able to replicate. This 
was the first indication that ghrelin may provide a gut-brain reward signal that is 
linked to feeding control at the level of the reward system. It seems rather likely that 
ghrelin accesses these reward circuits, especially as peripheral ghrelin injection has 
been shown to increase accumbal dopamine release [13]. The afferent stimulus pro-
vided by ghrelin could also be derived centrally, although it remains much debated 
whether ghrelin is produced in the brain as many research groups, including our own, 
have been unable to detect ghrelin mRNA in the brain by in situ hybridization. It can 
also be questioned whether an afferent ghrelin signal is required for GHS-R1A activa-
tion as the receptor appears to have constitutive activity in the absence of ligand [28] 
↑  Hedonic feeding
↑  Food intake, motivation,
reward, anticipation, ↑ taste
processing
↑  Homeostatic feeding
↑  Food intake
Ghrelin
Fig. 1. A simplified illustration 
of brain regions sensitive to 
ghrelin. Ghrelin is secreted 
from the stomach into the 
blood to activate at least two 
distinct brain pathways in-
volved in feeding. Activation 
of the homeostatic hypothala-
mus drives food intake. In ad-
dition to food intake, activa-
tion of hedonic pathways can 
also affect motivation and an-
ticipation for food.
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and may be able to modify dopamine signalling by heterodimerising with dopamine 
D1 receptors in, for example, ghrelin-sensitive neurones in the VTA [29].
The basic goal of feeding is to acquire calories and a diversity of nutrients. There is 
an obvious advantage in being able to detect a food high in energy, and one excellent 
indicator of this nutritional property is sweetness. Mammals appear to have an innate 
pre-disposition to preferentially eat sweet foods. Remarkably, rats trained to make a 
mutually exclusive choice between a behaviourally effective i.v. dose of cocaine or a 
short period of access to a sweet drink show a strong and sustained preference for the 
sweet taste [30]. Evidence suggests that ghrelin signalling may play an essential role 
in the motivation to consume sweet food over bland food. When given a free choice 
between bland food or sweet, palatable, energy-dense food, GHS-R1A receptor knock-
out mice and mice treated with a GHS-R1A receptor antagonist eat less palatable food 
than controls. Furthermore, palatable food consumption is usually associated with an 
increase in dopamine release in the NAcc but this is not observed in GHS-R1A knock-
outs [31]. In mice, the ability of sweet chocolate treats to condition a place preference 
is abolished by peripheral treatment with a GHS-R1A receptor antagonist [31] and is 
absent in fasted GHS-R1A receptor knockout mice [32]. Access to a pelleted high-fat 
NAcc
NPY
LH
Dopamine
Opioids
Opioids
Opioids
Orexin
Ghrelin
NPY
ARC
VTA
Fig. 2. Schematic illustration of brain pathways mediating ghrelin’s effects on food motivation. A key 
pathway involved in food motivation is the midbrain dopamine projection from the VTA to the NAcc. 
Ghrelin appears to activate this pathway directly at the level of the VTA. This provides a potential 
mechanism for ghrelin to promote food intake even when homeostatic hypothalamic centres such 
as the arcuate nucleus (ARC) or lateral hypothalamus (LH) indicate a state of satiety. It is also possible 
that ghrelin affects food motivation indirectly, for example, by activating an afferent pathway. Re-
cent studies suggest that while central opioid (via the mu receptor) and NPY (Y1 receptor) signalling 
are required for ghrelin’s effects on food motivation, the targets sites for these effects differ. At the 
level of the VTA, opioid signalling (but not NPY signalling) is required for ghrelin’s effects on food 
motivation [39].
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rodent diet also conditions a place preference in mice. This is enhanced by ghrelin 
administered peripherally but GHS-R1A receptor knockout mice show no such pref-
erence [33].
Building on serendipitous findings by Constantin Fahlberg in 1878, chemists are 
now able to produce molecules that are many hundred times sweeter than sucrose. 
These can therefore be used at very low concentrations, low enough to provide next 
to non-metabolisable energy. Saccharin is the prototypical artificial sweetener and 
rats will preferentially consume sweet-tasting saccharin solutions over water [34] but 
not in preference to approximately equally sweet natural, calorific sugars [35]. This 
gives rise to the idea of at least two aspects of reward driven by differing qualities in 
different foods; a gustatory reward (the pleasure of taste) and a post-ingestive reward 
(the pleasure associated with changes in plasma nutrient or hormonal levels). In ad-
dition to increasing sweet, caloric food intake, ghrelin also enhances sweet, non-ca-
loric saccharin intake both in the presence and absence of caloric food. Also, con-
sumption of a saccharin-sweetened food is reduced in GHS-R1A knockout mice com-
pared to wild-type mice [36].
If an animal finds food rewarding, it will show motivated behaviour to obtain it. 
This can be demonstrated in an operant conditioning paradigm in which rats must 
work progressively harder in order to obtain a sweet treat. Motivated behaviour for a 
sucrose reward is increased by ghrelin given centrally or peripherally to satiated rats 
and, conversely, is suppressed in hungry rats by a GHS-R1A antagonist, also admin-
istered by these routes [37]. Indeed ghrelin administration directly to the VTA, but 
not the NAcc, increases food-motivated behaviour, thereby identifying the VTA as 
the primary target for these effects of ghrelin [37]. Consistent with this, chemical le-
sion of the VTA reduces ghrelin-evoked food-motivated behaviour [38]. Using the 
same operant self-administration model of motivation for sucrose, pharmacological 
blockade of NPY receptors with intracentroventricular administration of a selective 
Y1 receptor antagonist prevents a ghrelin-evoked increase in motivation. This obser-
vation is recapitulated with an opioid receptor antagonist. In contrast, ghrelin’s local 
effects in the VTA on intake of normal bland food are unaffected by opioid receptor 
antagonism but are reduced by Y1 receptor blockade [39]. Interestingly, intra-VTA 
infusion of NPY antagonist does not prevent the potentiating effect of ghrelin on mo-
tivation suggesting that NPY activation to increase food motivation is at an extra-
VTA site, possibly the lateral hypothalamus or NAcc [39]. Taken together, this indi-
cates that central NPY and opioid receptor activation is required for ghrelin’s en-
hancement of sucrose motivation, but that in the VTA only opioid receptors are 
utilised by ghrelin for this response.
An important aspect of feeding-related behaviour is locomotion. An animal must 
forage or hunt for food before it can eat it. Ghrelin increases locomotion in mice when 
given centrally into the third ventricle [15] or more locally in the VTA or LDTg [13, 
31]. Rats fed for a restricted period each day quickly develop food-entrained anticipa-
tory activity (FAA) where a marked increase in locomotion is seen several hours pri-
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or to the time food is expected. Plasma ghrelin levels are specifically increased during 
a conditioned period of FAA in rats and physical activity levels can be reduced by 
intracebrovascular injection of a GHS-R1A receptor antagonist prior to the expected 
FAA [40]. Furthermore, decreased levels of FAA are observed in GHS-R1A receptor 
knockout mice. As well as conditioning FAA by restricted access to normal food, FAA 
can be evoked by restricted presentation of a palatable food in addition to ad lib access 
to normal food. When rats are given restricted access to a small amount of chocolate 
they show FAA similar to that seen in food-restricted animals and plasma ghrelin lev-
els are elevated compared to rats not anticipating the palatable reward. In addition, 
intracebrovascular ghrelin increases FAA for a reward while intracebrovascular ad-
ministration of a GHS-R1A receptor antagonist decreases it [41]. Thus, ghrelin ap-
pears to have a role in anticipatory activity for food, both predicted meals when hun-
gry and predicted additional food rewards when satiated.
What cellular and molecular mechanisms might underlie this important role for 
ghrelin in reward and motivation? After chronic intracebrovascular ghrelin adminis-
tration in rats, VTA dopamine D5 receptor mRNA and nicotinic acetylcholine nACh-
Rb2 receptor mRNA expression are increased whereas in the NAcc, there is reduced 
mRNA expression of dopamine D1A, D3 and D5 receptors and reduced expression 
of nicotinic acetylcholine nAChRa3 receptors [37]. Acute ghrelin administration to 
the VTA also upregulates opioid receptor mRNA in VTA neurones [39]. While it re-
mains to be determined whether these molecular-level changes are simply compensa-
tory responses to an enhanced dopamine signal for example, it is possible they could 
directly contribute to the rewarding effects of ghrelin. An increase in opioid receptor 
expression may underlie the interaction between ghrelin and opioids in the VTA, 
where a reward stimulus can elicit opioid release and concurrent ghrelin sensitises the 
VTA neuronal response to opioids by increasing opioid receptor expression. The 
presence of ghrelin could, therefore, make the stimulus of a single food reward much 
more motivating.
Less evidence exists for a role for ghrelin in modifying food reward in humans. Ex-
periments measuring hunger or the wanting and liking of foods in human subjects 
can be contentious, relying as they often do on subjective experience or self-reporting. 
However, in an fMRI study using satiated human subjects exposed to images of palat-
able foods, ghrelin increased a BOLD response in likely neural correlates of reward 
pathway activation such as the amygdala, orbitofrontal cortex and anterior insula, but 
not in the homeostatic hypothalamus [42].
Animals perform many natural goal-oriented behaviours that result in pleasure 
and reinforcement. After eating and drinking, the next most common of these is sex-
ual behaviour. Ghrelin has a partially characterised effect on hormonal reproductive 
physiology via actions on the hypothalamo-pituitary-gonadal axis. Ghrelin, like 
leptin, may be involved in the metabolic gating of the onset of puberty. For example, 
high plasma ghrelin levels may signal that insufficient energy is available for the de-
mands of sexual maturation [43]. In contrast, much less is known about a potential 
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role for ghrelin in sexual motivation and reward. In male mice administered an orex-
igenic dose of ghrelin, ultrasonic calling (a pre-copulatory courting behaviour) is re-
duced but the strong preference for females’ bedding observed in controls is neither 
enhanced nor reduced by ghrelin administration [44]. For males, sexual behaviour is 
not particularly costly, so moderate hunger (reflected by levels of ghrelin high in the 
physiological range) may not be a sufficient obstacle to prevent males taking advan-
tage of an opportunity to mate [45]. Nonetheless, it may be of interest to carefully de-
termine the effects of ghrelin on a place preference conditioned by a receptive female 
or her odour, on sexual incentive motivation tests or on the latency or number of in-
tromissions when male animals are allowed access to receptive females. In contrast to 
males, reproduction for females is extremely energetically expensive. In the context 
of reproduction perhaps energy stores are of more significance in females and sexual 
behaviours may be more susceptible to modification by energy balance signals. In-
deed, fasting or acute but not chronic ghrelin treatment can reduce sexual receptivity 
in female rats [46].
Conclusion: Ghrelin as a Reward Amplifier?
From an evolutionary perspective, ghrelin signalling may provide a strong driving 
force to ensure both an adequate nutritional supply and a diversity of food of varying 
reward value. It makes physiological sense that the empty stomach signals to neuro-
circuits involved in food motivation and craving, but this system can be hijacked by 
obesogenic foods in the modern Western lifestyle, contributing strongly to the devel-
opment of obesity. What is more, the effects of ghrelin on reward are not confined to 
natural rewards. Suppressed ghrelin signalling interrupts reward from chemical drugs 
of abuse such as alcohol [47], nicotine [48], cocaine and amphetamine [49]. More-
over, central ghrelin injection increases drug consumption and behaviours associated 
with the motivation for drugs. It should be noted, however, that ghrelin administra-
tion is itself rewarding, mice will show preference for an environment previously 
paired with ghrelin administration [50].
Possible targets for treatment by drugs modifying central ghrelin signalling are 
obesity, hypophagic diseases such as anorexia and forms of drug and alcohol abuse. 
The most prevalent of these is of course obesity. It is worthwhile noting that changes 
in circulating ghrelin are seen in obesity and after its treatment by bariatric surgery 
[51]. Furthermore, the concept of ghrelin resistance in homeostatic neural circuits 
after diet-induced obesity has been suggested [52], paralleling that of leptin resistance 
and insulin resistance manifesting as type 2 diabetes. Extending this idea to the moti-
vation to eat, mice made obese by a high-fat diet are less motivated to obtain food re-
wards in basal conditions and after ghrelin treatment; diet-induced obesity suppress-
es the stimulatory effect of ghrelin compared to lean mice [53]. It can be argued 
whether a major physiological role of ghrelin is to drive hunger or prevent starvation 
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but it is certain that ghrelin is orexigenic. Ghrelin’s actions in food motivation com-
plement this pro-feeding effect. It is clear that ghrelin is an important gut-brain signal 
for food intake driven by energy deficit or by an anticipated reward value.
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